Intrasense — Board/Management Information 2021

Jan 13, 2021

Montpellier, France January 13th 2021 – [08h00 AM]

New Group Chief Business Officer

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and designer of Myrian®, strengthens its management team with the appointment of Khalil Filali as Group Chief Business Officer.

Expertise in the medical imaging industry

Khalil Filali took office on January 4th, 2021 within the group. He is responsible for all commercial and marketing activities of Intrasense and will play a key role in the implementation of group's growth and development strategy, mainly in Europe and China.

With a strong experience in business development strategy as well as a large network acquired in the field of medical imaging (Philips Healthcare), Khalil is responsible for identifying and executing group commercial development opportunities. With multiple high-level experiences in corporate management and business development, he had the opportunity on multiple occasions to demonstrate his knowhow in the medical imaging sector.

Khalil Filali underlines: "I am very happy to join a fast-growing French group, I want to bring all my know-how to Intrasense teams and actively take part in the sustained and ambitious growth strategy put in place."

Khalil holds a postgraduate diploma in science "physics instruments marketing" as well as an executive master's degree in marketing management from ESSEC business school.

"Khalil's extensive experience in the healthcare industry, and more specifically in the medical imaging industry, is an important asset to the leadership Intrasense team. His experience in developing growth strategies will be key in building and executing the group's strategy. This appointment reinforces our objectives and our ambition for the years to come." Specifies Nicolas Reymond, CEO of Intrasense.

Press release

Growth at the heart of strategic challenges

In recent years, Intrasense demonstrated its ability to reposition itself and maintain significant growth while achieving operational profitability. The company is therefore committed to pursue its efforts and its ambitious strategy of maintaining strong growth in its key markets.

About Intrasense

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1000 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system. Intrasense has more than 40 employees among which 15 are dedicated to Research & Development. Intrasense has been labelled 'innovative company' by the BPI and has invested more than 10 million euros in Research & Development since its creation. More information on: www.intrasense.fr

Contacts

Intrasense Jérémy Peyron Marketing & Communication manager 1231 avenue du Mondial 98, 34000 Montpellier, FRANCE Tel: +334 67 130 130 investor@intrasense.fr

Roxane Gbedigro Paris, FRANCE Tel: +331 44 71 20 43 intrasense@newcap.eu

NewCap

Communication

Investor Relations and Financial